Press Releases
-
BOC Sciences Announces Featured PROTAC Design Services to Meet New Drug Discovery Goals
BOC Sciences announced featured PROTAC design services to customers around the world to meet new drug discovery goals.
Apr 28, 2022
-
PROTAC-based Methods as Traditional PROTAC Protein Degradation Technology Alternatives
Many emerging PROTAC-based technologies such as RNA-PROTACs and Photoswitchable PROTACs have expanded the scope of PROTAC development, providing more feasible potential strategies for the clinical treatment of related diseases.
Apr 28, 2022
-
Benefits of Stable Isotope Labelling in Biochemistry Research
Stable isotope labeling is a powerful technique with promising applications.
Apr 28, 2022
-
ADC Technology: A Premier Institution of Antibody-Drug Conjugates Development
ADC Technology releases a wide range of one-stop services related to ADC development such as antibody selection/modification, ADC payload and linker development, ADC conjugation, and ADC characterization and preclinical evaluation to help partners win the race of ADC research.
Apr 19, 2022
-
Elligo Health Research® Partners With Peoples Rx
Elligo Health Research and Peoples Rx Partner on Initiative to Help Share More Clinical Research Opportunities
Apr 28, 2022
-
Genovac further enhances its antibody discovery services with the ENPICOM IGX Platform
ENPICOM has announced that Genovac will use its IGX Platform for its antibody discovery workflows.
May 2, 2022
-
Scipio bioscience Announces Its Revolutionary Asteria© Single-cell RNA-seq Kit and Companion Cytonaut© Analysis Software Are Now Commercially Available
Scipio bioscience has announced that Asteria©, the latest breakthrough single-cell RNA-sequencing kit, is now commercially available for any researcher worldwide.
May 2, 2022
-
Matica Bio Opens New Cell and Gene Therapy GMP Facility in Texas
Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, today announced the opening of its new 45,000-square-foot facility dedicated to the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other genetic medicines.
May 2, 2022
-
CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development
CYTENA has entered a collaboration agreement with ExcellGene SA, a leading biologics CDMO that manufactures recombinant proteins.
May 2, 2022
-
Biotium Announces Acquisition of CAT5™ FFPE RNA/DNA Extraction Technology from Cell Data Sciences
Biotium is announcing the acquisition of Cell Data Sciences RNAstorm™ and DNAstorm™ kits for RNA/DNA extraction.
May 2, 2022
-
RefleXion Announces Real-World Evidence Outcomes Registry to Evaluate Treatment Impact on all Stages of Cancer
RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* for all stages of cancer, today announced the enrollment of the first patient into its PREMIER registry, a prospective, real-world evidence clinical outcomes registry for patients with all stages of cancer, at the University of Texas (UT) Southwestern in Dallas.
May 2, 2022
-
Creative Bioarray Provides Expertise in Delivering Comprehensive Pain Models to Support Pain Studies
-
Creative Bioarray Supplies Comprehensive Products to Support The Needs of Cell Culture Applications
-
DDA Platform Delivers Metabolic Stability Services to Accelerate Drug Discovery Procedures
-
Creative Biogene Generates Professional Cell Expression System to Accelerate Bioproduction Stable Cell Line Development
-
Qvirus Platform Optimized Lentivirus Production System for The Efficient design and Development of Lentivirus Vector
-
Microbiosci Develops Strain Selection and Fermentation Services to Accelerate The Development of Microbial Technologies
-
Drugs and alcohol consumption are the main causes of homelessness
I have been searching about lately. The type of details here on the forum is excellent and helpful and is going to assist my friends and I in our studies a couple times a week. It seems like all of the members here acquired a significant amount of info about this and other subjects and types of info like wise show it. I am not browsing websites most of the time although when I get an opportunity i'm usually avidly searching for this type of knowledge and things closely related to it. When anyone gets a chance, take a look at my website: [url=https://elpasodisabilitylawyer.com/practice-areas/]ssa attorney in san elizario, tx[/url]
May 4, 2022
-
CD Formulation Newly Launches Drug Packaging Services for the Pharmaceutical Industry
Packaging is another factor that decides the stability and integrity of drugs. Except for the role as an excipient producer and supplier, the US-based CRO company CD Formulation today announces that it newly launches a wide range of pharmaceutical packaging services, providing support throughout the whole process of packaging design, from material selection to chemical and surface analysis and to design selection.
May 4, 2022
-
Alfa Chemistry: Polymer Surfactants Have Exceptional Properties
With broad use in the manufacture of cleaning, pharmaceutical, cosmetic, and food products, the significance of polymer surfactants can never be neglected. In a recent statement, Alfa Chemistry announced the supply of a wide range of polymer surfactants for potential uses in both scientific research and industrial manufacturing.
May 4, 2022